The Division of Financial Regulation recently announced  permanent rulemaking repealing 836-053-0025, the regulation of the insulin co-pay amount for health benefit plans for the state, as a result of SB 1508 (2024) effective January 1, 2025.

Also in Oregon, the Division of Financial Regulation recently announced permanent rulemaking amending 836-052-1000, establishing and updating the list of prosthetic and orthotic devices; prohibiting internal or separate limits or caps on prosthetic and orthotic devices, other than the lifetime policy maximum, when permitted by law; and defining when coverage for prosthetic and orthotic device is provided through a managed care organization effective January 1, 2025.

Also in Oregon, the Prescription Drug Affordability Board (PDAB) posted an agenda and meeting materials for its December 18 meeting. You must register in advance to participate.

Finally in Oregon, the Oregon Prescription Drug Affordability Board has posted to the website the UPL report for the Oregon Legislature pursuant to ORS 646A.685.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

The December 11-12, 2024 Board of Pharmacy Meeting agenda and meeting materials are now available. Please note that on December 11, the board will meet in Executive Session immediately after recusal announcements and anticipates resuming Open Session between 4:00 pm-5:00 pm. Also please note that on December 12, the board will meet in Executive Session after roll call and anticipates resuming Open Session at 1:00 pm. The Public may attend the board meeting in person during Open Session. Please see the meeting agenda for additional meeting information. Please be advised that additional meeting materials may be added to the agenda prior to the board meeting. Visit the board website for current meeting materials.

Also in Oregon, the Prescription Drug Affordability Board (PDAB) posted an agenda for its December 18 meeting. Please note the “Board discussion and vote on both the policy recommendations for the Oregon Legislature and the annual report to the Oregon Legislature as well as the board’s receipt of the initial, preliminary list of prescription drugs and insulin for affordability review”. You must register in advance to participate.

Finally in Oregon, the Board of Pharmacy published its November 2024 Newsletter to Promote Pharmacy and Drug Law Compliance.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

The Oregon Health Authority announced the Immunization Policy Advisory Team will meet on December 5, 2024, from 12:00 noon-2:00 pm via Zoom. The final agenda will be available at the meeting or via email request three days before the meeting date by contacting imm.info@odhsoha.oregon.gov. Participation in the meeting requires registering in advance using this link. Those who register will receive a confirmation email with additional information.

Also in Oregon, the Drug Price Transparency Program (DPT) will host its annual hearing on December 4, 2024, at 10:00 am. The hearing will be held in person at 350 Winter St. NE, Salem and online. The agenda features panel discussions about drug advertising and drug rebates, along with an overview of the 2024 Drug Price Transparency report to the Oregon Legislature. Learn more on the DPT website and find the link to join the hearing online.

Finally in Oregon, the state is expected to beat its record of 910 pertussis (whooping cough) cases by the end of 2024. As of November 13, Oregon reported a total of 827 cases in 23 counties during 2024. At least one person, an older adult, has died. The Oregon Health Authority urges anyone over age 10 years who has not received the single-dose Tdap (tetanus, diphtheria, and pertussis) vaccine to get it now.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

The Prescription Drug Affordability Board (PDAB) posted an agenda and meeting materials for its November 20, 2024, meeting. Please note the “Board discussion and approval of SB 192 upper payment limit final report to send to the Oregon Legislature”. You must register in advance to participate.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

The Board of Pharmacy posted the November 7, 2024, Board Meeting agenda and meeting materials online. The board will meet in the Executive Session after discussing General Administration item (d.). The Public may attend the board meeting in person during the Open Session. Please see the meeting agenda for additional meeting information. Please be advised that additional meeting materials may be added to the agenda prior to the board meeting. Visit the board website for current meeting materials.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

The Prescription Drug Affordability Board (PDAB) posted a draft agenda for its October 16 meeting.  Please note the discussion of “Policy recommendations for the Oregon Legislature” and SB 192 upper payment limit study. You must register in advance of the meeting to participate.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

The Prescription Drug Affordability Board (PDAB) posted the agenda and meeting materials for its October 2 meeting. Please note the “Medicare MFP modeling presentation and SB 192 upper payment limit discussion” by PDAB staff and Myers and Stauffer on the agenda. You must register in advance of the meeting to participate.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

The Prescription Drug Affordability Board (PDAB) moved its next meeting from September 18 to October 2 due to unforeseen scheduling issues and lack of a quorum. The agenda has been updated to reflect this change. Please note the “Medicare MFP modeling presentation and SB 192 upper payment limit discussion” by PDAB staff and Myers and Stauffer on the agenda. You must register in advance of the meeting to participate.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

The Prescription Drug Affordability Board (PDAB) posted the draft agenda for its next meeting on September 18. Please note the “Medicare MFP modeling presentation and SB 192 upper payment limit discussion” by PDAB staff and Myers and Stauffer on the draft agenda. You must register in advance of the meeting to participate.

Also in Oregon, NACDS, as a participant in the PBM Working Group, submitted a letter to Rep. Rob Nosse (D), Chair, House Behavioral Health and Health Care Committee, to provide comments and pharmacy reimbursement concepts in advance of the next working group meeting scheduled to be held on September 18.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.